Status:
UNKNOWN
Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy
Lead Sponsor:
University of Catania
Conditions:
Non Proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Eligibility:
All Genders
40-65 years
Phase:
PHASE4
Brief Summary
Homocysteine, a well-known inducer of vascular endothelial cell damage has been associated with extracellular matrix changes. Many studies demonstrated that high levels of this aminoacid in diabetic p...
Eligibility Criteria
Inclusion
- diabetic patients with proliferative and non proliferative retinopathy
Exclusion
- Patients with chronic liver disease Patients with kidney disease.
Key Trial Info
Start Date :
September 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT01921192
Start Date
September 1 2012
Last Update
August 13 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Catania, Cannizzaro Hospital
Catania, Italy, 95125